- Home
- NMTC vs BCLI Comparison
NMTC vs BCLI Comparison
Compare NMTC & BCLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMTC
- BCLI
- Stock Information
- Founded
- NMTC 2009
- BCLI 2000
- Country
- NMTC United States
- BCLI United States
- Employees
- NMTC N/A
- BCLI N/A
- Industry
- NMTC Medical/Dental Instruments
- BCLI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NMTC Health Care
- BCLI Health Care
- Exchange
- NMTC Nasdaq
- BCLI Nasdaq
- Market Cap
- NMTC 27.7M
- BCLI 25.0M
- IPO Year
- NMTC N/A
- BCLI N/A
- Fundamental
- Price
- NMTC $0.79
- BCLI $1.10
- Analyst Decision
- NMTC
- BCLI Strong Buy
- Analyst Count
- NMTC 0
- BCLI 1
- Target Price
- NMTC N/A
- BCLI $30.00
- AVG Volume (30 Days)
- NMTC 97.0K
- BCLI 125.6K
- Earning Date
- NMTC 12-12-2024
- BCLI 11-22-2024
- Dividend Yield
- NMTC N/A
- BCLI N/A
- EPS Growth
- NMTC N/A
- BCLI N/A
- EPS
- NMTC N/A
- BCLI N/A
- Revenue
- NMTC $3,922,499.00
- BCLI N/A
- Revenue This Year
- NMTC $109.53
- BCLI N/A
- Revenue Next Year
- NMTC $90.00
- BCLI N/A
- P/E Ratio
- NMTC N/A
- BCLI N/A
- Revenue Growth
- NMTC N/A
- BCLI N/A
- 52 Week Low
- NMTC $0.60
- BCLI $1.05
- 52 Week High
- NMTC $2.00
- BCLI $11.85
- Technical
- Relative Strength Index (RSI)
- NMTC 41.71
- BCLI 18.33
- Support Level
- NMTC $0.83
- BCLI $1.12
- Resistance Level
- NMTC $0.94
- BCLI $1.95
- Average True Range (ATR)
- NMTC 0.07
- BCLI 0.20
- MACD
- NMTC -0.01
- BCLI -0.02
- Stochastic Oscillator
- NMTC 20.42
- BCLI 1.75
About NMTC NeuroOne Medical Technologies Corporation
NeuroOne Medical Technologies Corp operates as a medical technology company. It is focused on the development and commercialization of thin-film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, brain stimulation, and ablation solutions for patients suffering from brain-related disorders. The company business is in one operating segment, which is the business of development and commercialization of products related to comprehensive neuromodulation cEEG and sEEG recording, monitoring, ablation, and brain stimulation solutions.
About BCLI Brainstorm Cell Therapeutics Inc.
Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Progressive Multiple Sclerosis (PMS), and Parkinson's disease (PD). Brainstorm's NurOwn, its proprietary process for the propagation of Mesenchymal Stem Cells (MSC) and differentiation into neurotrophic factor-(NTF) secreting cells (MSC-NTF), and their transplantation at, or near, the site of damage, offers the hope of more effectively treating neurodegenerative diseases.